Therapies based on GLP-1 receptor agonists: significance, challenges, and opportunities.

Saved in:
Bibliographic Details
Title: Therapies based on GLP-1 receptor agonists: significance, challenges, and opportunities.
Authors: Jackson-Morris A; World Obesity Federation, London EC1N 2SW, UK. Electronic address: ajacksonmorris@worldobesity.org., Halpern B; World Obesity Federation, London EC1N 2SW, UK; Obesity Group, Department of Endocrinology, University of São Paulo, Brazil., Segafredo G; Medicine Patients Pool Foundation, Geneva, Switzerland., Baur L; World Obesity Federation, London EC1N 2SW, UK; The University of Sydney, Sydney Medical School, Sydney, NSW, Australia., Sealey K; World Obesity Federation, London EC1N 2SW, UK; Health Caribbean Coalition, St Michael, Barbados., Kushner RF; Departments of Medicine and Medical Education, Northwestern University Feinberg School of Medicine, Chicago, IL, USA., Sperling L; Hubert Department of Global Health, Rollins School of Public Health at Emory University, Atlanta, GA, USA; World Heart Federation, Geneva, Switzerland., Mutungi H; Medicine Patients Pool Foundation, Geneva, Switzerland., Schwarz P; International Diabetes Federation, Brussels, Belgium., Buse K; World Obesity Federation, London EC1N 2SW, UK; Monash University of Malaysia, Kuala Lumpur, Malaysia., Ralston J; World Obesity Federation, London EC1N 2SW, UK.
Source: The Lancet. Global health [Lancet Glob Health] 2026 Apr; Vol. 14 (4), pp. e488-e489. Date of Electronic Publication: 2026 Feb 25.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Ltd Country of Publication: England NLM ID: 101613665 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2214-109X (Electronic) Linking ISSN: 2214109X NLM ISO Abbreviation: Lancet Glob Health Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
Description
ISSN:2214-109X
DOI:10.1016/S2214-109X(26)00009-4